NCT01955421
Erlotinib 100mg qd Versus Gefitinib 250mg qd for EGFR Mutant Nsclc treatment 2 unknown_status NCT05701176
A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer No drug interventions diagnostic Not Available recruiting NCT02350764
Evaluate the Mediators of Sensitivity and Resistance to Nivolumab Plus Ipilimumab in Patients With Advanced NSCLCs treatment 2 completed NCT01101334
Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer treatment 2 completed NCT01646125
An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations treatment 2 terminated NCT04982224
Study of REGN5093-M114 (METxMET Antibody-Drug Conjugate) in Adult Patients With Mesenchymal Epithelial Transition Factor (MET) Overexpressing Advanced Cancer treatment 1 / 2 recruiting NCT05609578
Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation treatment 2 recruiting NCT06613633
Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC: a Prospective, Observational Study Not Available Not Available completed NCT06604689
AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain Metastases Not Available Not Available not_yet_recruiting NCT04229121
Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients No drug interventions Not Available Not Available unknown_status NCT01211483
Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung Cancer treatment 1 / 2 completed NCT00813332
Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC) treatment 4 unknown_status NCT06356675
A Single-arm Pilot Study of Tislelizumab Combined With Anlotinib in Patients With Advanced NSCLC With Driver-negative After Progression to Immunotherapy treatment 4 not_yet_recruiting NCT02133196
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer treatment 2 recruiting NCT04992858
Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations treatment 2 not_yet_recruiting NCT05219162
Real-World Study on Gene Profile in Patients With Advanced NSCLC Who Progressed on First-Line Osimertinib Therapy(GPS). No drug interventions diagnostic 4 completed NCT03215810
Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer treatment 1 completed NCT04043195
Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC treatment 1 / 2 active_not_recruiting NCT02055508
POSITIVE - Study (Part III) Heidelberg No drug interventions supportive_care Not Available completed NCT03062800
Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003) treatment 2 unknown_status NCT03074175
Plasma miRNAs Predict Radiosensitivity of Different Fractionation Regimes in Palliative Radiotherapy for Advanced Non-small Cell Lung Cancer：Multicenter Controlled Study.(RadmiR-01) No drug interventions treatment Not Available completed NCT03127449
AST2818 in Advanced Non-Small Cell Lung Cancer With EGFR Mutations treatment Not Available unknown_status NCT05859217
A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1) treatment 2 not_yet_recruiting NCT05106335
A Study to Evaluate Camrelizumab Combined With Famitinib as Subsequent Therapy in Patients With Advanced NSCLC treatment 3 terminated NCT04613596
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 treatment 2 / 3 recruiting NCT05099172
First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2) No drug interventions treatment 1 / 2 recruiting NCT05557591
A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1) treatment 2 recruiting NCT05607550
Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT) treatment 3 recruiting NCT05676931
Study With Immunotherapy Combinations in Participants With Metastatic Non-Small Cell Lung Cancer treatment 2 recruiting NCT05777603
Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung Cancer treatment 1 recruiting NCT06269133
Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Patients Not Available Not Available active_not_recruiting NCT06279728
Medical Access Program for Datopotamab Deruxtecan in NSCLC Patients Not Available Not Available available NCT06406166
Lifei Xiaoji Wan in Treatment of Advanced NSCLC No drug interventions treatment Not Available recruiting NCT06452277
A Study to Learn More About How Well BAY 2927088 Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Human Epidermal Growth Factor Receptor 2 (HER2) treatment 3 recruiting NCT03334864
Observational Cohort Study of Advanced Non-small Cell Lung Cancer (CAPTRA-LUNG) No drug interventions Not Available Not Available recruiting NCT04733521
A Phase 1/2 Study of SC-43 in Combination With Cisplatin treatment 1 / 2 unknown_status NCT05904379
AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer treatment 1 / 2 recruiting NCT04818333
A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer No drug interventions treatment 1 / 2 active_not_recruiting NCT02200354
The Safety and Efficacy of Pemetrexed Rechallenge With Bevacizumab treatment 2 terminated NCT01551251
Tumor Associated Macrophage in Advanced Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT04032847
ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC treatment 1 / 2 recruiting NCT00983047
Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer treatment 2 terminated NCT03856697
Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation treatment 3 unknown_status NCT03681483
RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer treatment 1 completed NCT02157883
Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva) other 1 completed NCT05303493
Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma No drug interventions treatment 1 recruiting NCT00783471
Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC) treatment 2 terminated NCT05504278
Efficacy and Safety of IBI351 in Combination With Sintilimab ± Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation treatment 1 recruiting NCT06348888
A Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy Participants other 1 completed NCT03371485
AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer No drug interventions treatment 1 completed NCT01802632
AZD9291 First Time In Patients Ascending Dose Study treatment 1 / 2 completed NCT03326752
Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLC treatment 1 completed NCT00345059
The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer treatment 3 terminated NCT04541706
Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in India treatment 4 completed NCT00064636
Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors treatment 1 terminated NCT01631136
Strategies for Maintenance Therapies in Advanced Non Small Cell Lung Cancer treatment 3 completed NCT02175017
ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT03948724
Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology No drug interventions prevention Not Available active_not_recruiting NCT04922658
Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer treatment 2 recruiting NCT05287386
A Single-Arm Phase II Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients With FGFR Alterations Who Have Failed Standard Therapy treatment 2 recruiting NCT06174857
Efficacy of Osimertinib in Patients With Lung Cancer No drug interventions Not Available Not Available recruiting NCT02143466
AZD9291 in Combination With Ascending Doses of Novel Therapeutics treatment 1 active_not_recruiting NCT04785365
Long-Term Follow-Up Study of Patients Receiving ATL001 No drug interventions other 2 terminated NCT05435274
Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer No drug interventions treatment 1 / 2 recruiting NCT05489731
VIC-1911 Combined With Osimertinib for EGFR -Mutant Non-small Cell Lung Cancer treatment 1 recruiting NCT00786331
Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC treatment 2 unknown_status NCT05364073
Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations treatment 1 active_not_recruiting NCT02952729
Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2 No drug interventions treatment 1 completed NCT02964689
Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC. treatment 1 completed NCT03727867
Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Early Stereotactic Body Radiation Therapy to the Primary Tumor in Advanced Non-small Cell Lung Cancer treatment 3 unknown_status NCT05978401
Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer treatment 1 / 2 not_yet_recruiting NCT04886401
Retrospective Observational Study on Prediction of Response to PD-1 Immunotherapy in Patients With NSCLC No drug interventions Not Available Not Available unknown_status NCT05652868
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer No drug interventions treatment 1 recruiting NCT00708812
Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer treatment 2 completed NCT03516981
A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495) treatment 2 active_not_recruiting NCT06329895
A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants other 1 completed NCT00319514
Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC treatment 2 completed NCT03452150
D-0316 First Time in Patients Ascending Dose Study treatment 1 completed NCT05380908
Brain Metabolic Network of PET in Patients With Advanced Non-Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT04144608
Toripalimab Combined With Double Platinum-based Chemotherapy for Initially Unresectable NSCLC treatment 2 completed NCT04755738
Almonertinib Plus Microwave Ablation in Advanced Non-small Cell Lung Cancer treatment 2 not_yet_recruiting NCT04239443
Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer treatment 2 unknown_status NCT06434103
Clinical Study of SHR-A1921 Combined With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatment of Advanced NSCLC treatment 1 / 2 not_yet_recruiting NCT05499390
AK112 in Advanced Non-Small Cell Lung Cancer treatment 3 active_not_recruiting NCT02108964
A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies treatment 1 / 2 completed NCT04455984
Multimodality Treatment Including Curative Resection of Advanced NSCLC No drug interventions Not Available Not Available unknown_status NCT00602433
Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib No drug interventions Not Available Not Available completed NCT02163733
Study to Determine the Effect of Food on the Blood Levels of AZD9291 Following Oral Dosing of a Tablet Formulation in Patients With Non-Small Cell Lung Cancer other 1 completed NCT00651833
Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung Cancer No drug interventions treatment 2 completed NCT04263051
Evaluation of UCPVax Plus Nivolumab as Second Line Therapy in Advanced Non Small Cell Lung Cancer treatment 2 active_not_recruiting NCT01649947
Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II treatment 2 completed NCT01240447
Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients treatment 2 completed NCT03693547
Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC） treatment 2 completed NCT00652561
Phase 2 Study of S-1 as 2nd Line Therapy in Advanced Non-Small Cell Lung Cancer No drug interventions treatment 2 completed NCT03351361
Nivolumab and Ipilimumab Versus Chimiotherapy in First Line Treatment in PS 2 or Elderly in Advanced NSCLC Patients treatment 3 completed NCT00874328
A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) treatment 1 / 2 unknown_status NCT06360211
A Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants other 1 completed NCT00161278
Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling treatment 2 terminated NCT06585059
Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers treatment 1 not_yet_recruiting NCT00948675
Study of Participants With Advanced Non-Small Cell Lung Cancer treatment 3 completed NCT05416775
Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer treatment 1 / 2 recruiting NCT06221475
A Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants No drug interventions other 1 completed NCT02038699
A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer treatment 1 / 2 withdrawn NCT00385606
Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC treatment 2 / 3 completed NCT00349219
TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung Cancer treatment 3 completed NCT02639234
Vigil™ + Nivolumab in Advanced Non-Small Cell Lung Cancer treatment 2 withdrawn NCT05910034
Envafolimab Plus Docetaxel In Combination With or Without Trilaciclib Versus Docetaxel in Advanced NSCLC treatment 2 not_yet_recruiting NCT05001724
KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 Agent treatment 2 / 3 terminated NCT06378658
A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants other 1 completed NCT04685135
Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation treatment 3 active_not_recruiting NCT03117335
Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer treatment 3 completed NCT04990063
Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC) No drug interventions treatment 1 unknown_status NCT02582125
ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT03014648
Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC) treatment 2 completed NCT03652857
Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer treatment 2 completed NCT04049474
Bronchoscopic Cryo-Immunotherapy of Lung Cancer No drug interventions treatment 0 active_not_recruiting NCT06107374
Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG No drug interventions diagnostic 2 not_yet_recruiting NCT05004974
Sintilimab With Pemigatinib in Patients With PD-L1-positive and FGFR Mutated Advanced Non-small Cell Lung Cancer treatment 2 recruiting NCT05420220
Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer treatment 2 recruiting NCT00072631
Erlotinib (Tarceva (Trademark), OSI-774) in Treating Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT06043973
Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance treatment 3 recruiting NCT05318573
A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer treatment 2 recruiting NCT02407327
Individualized Treatment of Patients With Advanced NSCLC: Potential Application for Circulating Tumor Cells (CTC) Molecular and Phenotypical Profiling No drug interventions Not Available Not Available completed NCT00633789
Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types treatment 2 completed NCT00737867
Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer treatment 3 completed NCT05215067
A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer treatment 2 unknown_status NCT05785767
A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 2 / 3 recruiting NCT05482568
A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer treatment 1 / 2 recruiting NCT00487669
Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC) treatment 2 completed NCT00330746
CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer treatment 2 completed NCT01980212
Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT05192681
Tislelizumab as Cross-line Treatment for Advanced NSCLC treatment 2 unknown_status NCT04699123
The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer treatment 2 recruiting